Tag Archives: University of Texas

August, 2018

9 August
Jazz and MD Anderson Partner to Evaluate Potential Therapies for Hematologic Malignancies

DUBLIN and HOUSTON, Aug. 6, 2018 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and The University of Texas MD Anderson Cancer Center today announced a five-year collaboration agreement with a goal of evaluating therapies for multiple hematologic malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndromes. The joint effort brings …
Share

18 August
Biocept and UT Southwestern Medical Center Announce Study to Profile & Monitor NSCLC Cancer Patients with ALK Rearrangements

SAN DIEGO, Aug. 17, 2017 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces it has entered into a clinical study agreement with the University of Texas Southwestern Medical …
Share

2 November
MD Anderson-Led Study Develops Prediction Model for Lung Cancer Risk in Never Smokers

Researchers at The University of Texas MD Anderson Cancer Center have developed a new personalized assessment tool that could better predict lung cancer risk in never, light and heavy smokers using a large Taiwanese prospective cohort study. By incorporating risk factors in addition to smoking history, this tool could better …
Share

31 March
Cancer Gone…But Challenges Remain

Even years after cancer enters remission or is cured, the story is not necessarily over. There is evidence from multiple sources showing that side effects and related issues can linger, causing ongoing problems for cancer survivors. Bringing this little-known problem into the light of day can help cancer survivors deal …
Share